No crash diets here
Because high-quality safety data for subcutaneous lipotropic therapy is still limited, its especially important to report any unusual or persistent symptoms to your care team and to seek prompt medical attention for severe reactions such as difficulty breathing, chest pain, or signs of an allergic reaction
GLP-1 Pipeline In November 2023, the FDA approved Zepbound (tirzepatide), a GLP-1 antagonist and GIP dual agonist with superior weight loss efficacy compared to its competitors
With GLP-1 injections, it bypasses the digestive system, which leads to direct absorption into the bloodstream
However, adding even light movement can improve results and provide additional health benefits beyond weight loss
No, Ozempic (semaglutide) is not made from Gila monster venom